Background In Hong Kong, one of six couples is affected by subfertility problems. Male infertility contributes to half of the infertility cases. In male infertility, there is no effective treatment for patients with idiopathic infertility/poor semen parameters. Recent meta-analysis results suggest that a traditional Chinese medicine (TCM) formula — Wuzi Yanzong pill — showed a curative effect on male fertility. However, the heterogeneity of the studies could not draw a definitive conclusion on the therapeutic effect of this formula. The aim of this study is to conduct a well-designed randomized controlled trial to investigate the effect of TCM formula Wuzi Yanzong pill on improving semen qualities in men with suboptimal parameters. Methods This study is a double-blinded, randomized placebo-controlled trial conducted in a public hospital in Hong Kong. Participants will be randomized, using computer-generated random numbers, with a 1:1 ratio to either the Wuzi Yanzong pill formula group or the placebo group. Both groups will be administered the drugs for 12 weeks. Participants will have a total of four visits for their semen and blood assessments for a 6-month period, and we will follow up for another 6 months to record their conception outcome. The primary outcome is to compare the total motile sperm count, natural conception rate, and pregnancy outcome to those under placebo treatment. Secondary objectives are sperm functions and assisted reproductive technology outcome. Discussion To date, there are no studies using the disclosed Wuzi Yanzong formula or double-blinded, randomized trials. The Wuzi Yanzong TCM formula may provide a good clinical solution for subfertile males for which contemporary western medicine has no cure. Therefore, a well-designed randomized trial for evaluating the effect of Wuzi Yanzong TCM formula is urgently needed. Trial registration Chinese Clinical Trial Registry (ChiCTR), ChiCTR-INR-17010790 . Registered on 27 February 2017. Centre for Clinical Research and Biostatistics - Clinical Trials Registry, CUHK_CCRB00548 . Registered on 27 February 2017. Electronic supplementary material The online version of this article (10.1186/s13063-019-3647-2) contains supplementary material, which is available to authorized users.
Background In Hong Kong, one of six couples is affected by subfertility problems. Male infertility contributes to half of the infertility cases. In male infertility, there is no effective treatment on patients with idiopathic infertility/poor semen parameters. Recent meta-analysis suggests that a traditional Chinese medicine formula — Wuzi Yanzong Pill showed the curative effect on male fertility. However, the heterogeneity of the studies could not draw a definitive conclusion on the therapeutic effect of this formula. The aim of this study is to conduct a well-designed randomized controlled trial to investigate the effect of Traditional Chinese Medicine formula Wuzi Yanzong Pill on improving semen qualities in men with sub-optimal parameters. Methods This study is a double-blinded, randomized placebo-controlled trial conducted in a public hospital in Hong Kong. Participants will be randomized 1:1 ration either the Wuziyanzong Pill formula group or the placebo group using the computer-generated random number. Both groups will administrate the drugs for 12 weeks. Participants will have total four visits for their semen and blood assessments for a six-month period and we will follow up for another six months to record their conception outcome. The primary outcome is to compare the total motile sperm count, natural conception rate and pregnancy outcome to that under placebo treatment. Secondary objects are sperm functions and assisted reproductive technology outcome. Discussion To date, there are none of the studies using the disclosed Wuzi Yanzong formula nor double-blinded, randomized trials. The Wuzi Yanzong TCM formula may provide a good clinical solution for subfertile males that contemporary western medicine has no cure. Therefore, a well-designed randomized trial for evaluating the effect of Wuzi Yanzong TCM formula is urgently needed. Trial registration: Chinese Clinical Trial Registry (ChiCTR), ChiCTR-INR-17010790 Registered on 27/02/2017. http://www.chictr.org.cn/showproj.aspx?proj=18356 Centre for Clinical Research and Biostatistics, Clinical Trials Registry, CUHK_CCRB00548. Registered on 27/02/2017. https://www2.ccrb.cuhk.edu.hk/registry/public/437
Background In Hong Kong, one of six couples is affected by subfertility problems. Male infertility contributes to half of the infertility cases. In male infertility, there is no effective treatment on patients with idiopathic infertility/poor semen parameters. Recent meta-analysis suggests that a traditional Chinese medicine formula — Wuzi Yanzong Pill showed the curative effect on male fertility. However, the heterogeneity of the studies could not draw a definitive conclusion on the therapeutic effect of this formula. The aim of this study is to conduct a well-designed randomized controlled trial to investigate the effect of Traditional Chinese Medicine formula Wuzi Yanzong Pill on improving semen qualities in men with sub-optimal parameters. Methods This study is a double-blinded, randomized placebo-controlled trial conducted in a public hospital in Hong Kong. Participants will be randomized 1:1 ration either the Wuziyanzong Pill formula group or the placebo group using the computer-generated random number. Both groups will administrate the drugs for 12 weeks. Participants will have total four visits for their semen and blood assessments for a six-month period and we will follow up for another six months to record their conception outcome. The primary outcome is to compare the total motile sperm count, natural conception rate and pregnancy outcome to that under placebo treatment. Secondary objects are sperm functions and assisted reproductive technology outcome. Discussion To date, there are none of the studies using the disclosed Wuzi Yanzong formula nor double-blinded, randomized trials. The Wuzi Yanzong TCM formula may provide a good clinical solution for subfertile males that contemporary western medicine has no cure. Therefore, a well-designed randomized trial for evaluating the effect of Wuzi Yanzong TCM formula is urgently needed. Trial registration: Chinese Clinical Trial Registry (ChiCTR), ChiCTR-INR-17010790 Registered on 27/02/2017. http://www.chictr.org.cn/showproj.aspx?proj=18356 Centre for Clinical Research and Biostatistics, Clinical Trials Registry, CUHK_CCRB00548. Registered on 27/02/2017. https://www2.ccrb.cuhk.edu.hk/registry/public/437
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.